NCT06518928 SprmPik AI Sperm Selection Study SiD, an Assistant for Sperm Selection During Intracytoplasmic Sperm Injection in Medically Assisted Reproduction: Effect on Fertilization, Blastocyst Formation, Early Pregnancy Loss, and Consistent Practice. A Prospective Pilot Study.
| NCT ID | NCT06518928 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ovation Fertility |
| Condition | Infertility |
| Study Type | OBSERVATIONAL |
| Enrollment | 155 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 155 participants in total. It began in 2024-01-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
SprmPik AI Assisted Sperm Selection Study SiD, an assistant for sperm selection during intracytoplasmic sperm injection in medically assisted reproduction: effect on fertilization, blastocyst formation, early pregnancy loss, and consistent practice. A prospective pilot study.
Eligibility Criteria
Inclusion criteria for Male Partner (sperm source) * Informed consent signed by the patient before treatment. * IVF treatments with medical or embryology indication to perform ICSI. * Fresh or frozen ejaculated motile sperm. * Selection of sperm using a 7% or 10% PVP solution. * Presence of motile sperm at the time of sperm selection for ICSI. * Partner sperm Exclusion criteria for Male Partner (sperm source) * Sperm extracted by testicular biopsy. * That the recommendations for use of SiD have not been fully followed. * Inability to reliably trace sperm-oocyte-embryo throughout the process. * Patients with immotile sperm Inclusion criteria for Female Partner (egg source) * Informed consent signed by the patient before treatment. * IVF treatments with medical or embryology indication to perform ICSI. * Cycles with at least 4 mature oocytes (Metaphase II). * Fresh or frozen oocytes. Exclusion criteria for Female Partner (egg source) * Inability to reliably trace sperm-oocyte-embryo throughout the process. * Oocytes that are not in Metaphase II.
Frequently Asked Questions
Who can join the NCT06518928 clinical trial?
This trial is open to participants of all sexes, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06518928 currently recruiting?
Yes, NCT06518928 is actively recruiting participants. Visit ClinicalTrials.gov or contact Ovation Fertility to inquire about joining.
Where is the NCT06518928 trial being conducted?
This trial is being conducted at Las Vegas, United States, Austin, United States.
Who is sponsoring the NCT06518928 clinical trial?
NCT06518928 is sponsored by Ovation Fertility. The trial plans to enroll 155 participants.